Approved by the Food and Drug Administration in 2010, a blood-thinner called Pradaxa was a great leap forward in the treatment of a heart disorder called atrial fibrillation. Or at least that’s how it was marketed. There was just one slight problem: Unlike the drug it was meant to replace,…